
zzso protein zzso zzso an zzso that zzso the first step in the zzso modification of zzso and a number of other zzso has emerged as an important target for the development of zzso zzso zzso is one of the first zzso zzso to undergo clinical zzso We report a Phase I trial to assess the maximum tolerated dose, zzso and biological effectiveness of zzso in zzso zzso in zzso Twenty patients with solid tumors received 92 courses of escalating zzso doses given orally twice a day zzso for 7 days out of every 3 zzso zzso toxicity zzso zzso and zzso and fatigue were zzso at 400 zzso of zzso zzso zzso zzso zzso zzso secondary to zzso from gastrointestinal zzso was also zzso zzso of zzso A zzso in zzso zzso cells of patients treated with zzso was demonstrated, confirming that zzso zzso protein zzso in zzso One partial response was observed in a patient with previously treated zzso zzso cell lung cancer, who remained on study for 14 zzso This study not only establishes the dose for future testing on this schedule zzso zzso zzso but also provides the first evidence of successful zzso of zzso in the clinical setting and the first hint of clinical activity for this class of zzso 

